Issues and updates: evaluating estrogen receptor-α, progesterone receptor, and HER2 in breast cancer | Modern Pathology
IVD Antibody & Immunoassay Development Services for HER2 Biomarker - Creative Biolabs
Biologicals to direct nanotherapeutics towards HER2-positive breast cancers - ScienceDirect
Breast cancer: a new target? | Recherche animale
/diagnosis-and-testing-for-her2-positive-breast-cancer-4151804-53c6bdb1bb654ed69ce7f967626b7e4e.png "HER2 Positive and Negative Breast Cancers: Aggressiveness, Treatment, and Survival")
HER2 Positive and Negative Breast Cancers: Aggressiveness, Treatment, and Survival
Therapeutic targeting of HER2–CB2R heteromers in HER2-positive breast cancer | PNAS
Spatially resolved determination of the abundance of the HER2 marker in microscopic breast tumors using targeted SERS imaging | SpringerLink
Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update - ScienceDirect
Nuclear Y-Box Binding Protein-1, a Predictive Marker of Prognosis, Is Correlated with Expression of HER2/ErbB2 and HER3/ErbB3 in Non-small Cell Lung Cancer - Journal of Thoracic Oncology
Study of ER, PR, HER2/neu, p53, and Ki67 expression in primary breast carcinomas and synchronous metastatic axillary lymph nodes
Anti Human HER2/neu Antibody, clone ICR55 | Bio-Rad
Pathology Outlines - HER2 (c-erbB2) breast
Identification of gene markers for HER2+, Luminal A/B and TNBC. (A)... | Download Scientific Diagram
Breast cancer: a new target? | Recherche animale
Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity | Journal of Nanobiotechnology | Full Text
Automated detection of the HER2 gene amplification status in Fluorescence in situ hybridization images for the diagnostics of cancer tissues | Scientific Reports
Medicina | Free Full-Text | Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities | HTML
NFk B drives stemness and resistance to therapy in ER+HER2- breast cancer | Oncotarget
Table 2 | TOP2A amplification in breast cancer is a predictive marker of anthracycline-based neoadjuvant chemotherapy efficacy | SpringerLink
PLOS ONE: HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss
A novel HER2-targeting antibody 5G9 identified by large-scale trastuzumab-based screening exhibits potent synergistic antitumor activity - EBioMedicine
Updated UK Recommendations for HER2 assessment in breast cancer | Journal of Clinical Pathology
HER2 expression in primary breast cancer tissues. ( A ), Western blot... | Download Scientific Diagram
STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits
